International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8053466
Original Article
Study of Risk Factors and Outcome of Respiratory Distress in Neonates Admitted In Neonatal Intensive Care Unit in a Tertiary Care Hospital
 ,
 ,
Published
June 19, 2023
Abstract
Background: Respiratory distress (RD) is a challenging problem and is one of the most common causes of admission in neonatal intensive care unit. The objective was to study the various Risk factors associated with development of severe respiratory distress in the new born and to determine the severity and outcome of neonates with Respiratory distress. Methods: A Retrospective Cross Sectional Study was conducted at Department of Paediatrics, Smt. Kashibai Navale Medical College & General Hospital, Pune. The study recruited all babies admitted in NICU diagnosed as Respiratory Distress between May 2020 to April 2022. The data was collected from records of patients files admitted during the study period. The variables studied were antenatal, natal, postnatal risk factors, clinical course, staging and final outcome for all diagnosed babies. Results: During the study period, total 70 cases of RD admitted to NICU were recruited, among them 7 deaths were recorded in total. The most common cause of neonatal respiratory distress was Transient Tachypnea of Newborn [TTN] 34 (48%) followed by Respiratory Distress Syndrome 19(27%). Third cause was birth asphyxia 06 (8%). Conclusion: Respiratory distress was the major cause of admission in our NICU. Caesarean section was the most common predisposing factor associated with the development of respiratory distress in neonates. Antenatal risk factors increase the incidence of RD. The most common causes of respiratory distress were TTN, RDS, Meconium Aspiration Syndrome [MAS] and perinatal asphyxia. The common cause of death was Hyaline Membrane Disease. The outcome of neonatal respiratory distress was found as:a survival rate of 90%, mortality rate of 10%.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
309 Views
397 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved